An Afferent Vagal Nerve Pathway Links Hepatic PPARα Activation to Glucocorticoid-Induced Insulin Resistance and Hypertension

Cell Metabolism

Volumn 5, Issue 2, 2007, Pages 91-102

  Bernal Mizrachi, Carlos ^a   Xiaozhong, Liu ^a   Yin, Li ^a   Knutsen, Russell H ^a   Howard, Michael J ^a   Arends, Joop J A ^a   DeSantis, Pascual ^a   Coleman, Trey ^a   Semenkovich, Clay F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HUMDISEASE

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOSE; INSULIN; LEPTIN; NORADRENALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RENIN; SODIUM;

ADRENERGIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SELECTIVE VAGOTOMY; SENSORY NERVE; SODIUM RETENTION; VAGUS NERVE;

AFFERENT PATHWAYS; ANIMALS; BLOOD PRESSURE; DEXAMETHASONE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; HYPERTENSION; INSULIN RESISTANCE; LIVER; MICE; MICE, INBRED C57BL; PPAR ALPHA; RNA, MESSENGER; VAGOTOMY; VAGUS NERVE;

ANIMALIA; MUS;

EID: 33846622807     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2006.12.010     Document Type: Article

References (47)

1. Bellinger L.L., and Williams F.E. The effects of liver denervation on food and water intake in the rat. Physiol. Behav. 26 (1981) 663-671
2. Benthem L., Keizer K., Wiegman C.H., de Boer S.F., Strubbe J.H., Steffens A.B., Kuipers F., and Scheurink A.J. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1286-E1293
3. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 53 (2002) 409-435
4. Bernal-Mizrachi C., Weng S., Li B., Nolte L.A., Feng C., Coleman T., Holloszy J.O., and Semenkovich C.F. Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 961-968
5. Bernal-Mizrachi C., Weng S., Feng C., Finck B.N., Knutsen R.H., Leone T.C., Coleman T., Mecham R.P., Kelly D.P., and Semenkovich C.F. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat. Med. 9 (2003) 1069-1075
6. Berthoud H.-R., and Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Auton. Neurosci. 85 (2000) 1-17
7. Berthoud H.-R., Kressel M., and Neuhuber W.L. An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system. Anat. Embryol. (Berl.) 186 (1992) 431-442
8. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., and Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
9. Cardin S., Walmsley K., Neal D.W., Williams P.E., and Cherrington A.D. Involvement of the vagus nerves in the regulation of basal hepatic glucose production in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E958-E964
10. Chakravarthy M., Pan Z., Zhu Y., Tordjman K., Schneider J., Coleman T., Turk J., and Semenkovich C.F. "New" hepatic fat activates PPARα to maintain glucose, lipid and cholesterol homeostasis. Cell Metab. 1 (2005) 309-322
11. Grekin R.J., Vollmer A.P., and Sider R.S. Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension 26 (1995) 193-198
12. Grekin R.J., Dumont C.J., Vollmer A.P., Watts S.W., and Webb R.C. Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273 (1997) R324-R330
13. Guerre-Millo M., Rouault C., Poulain P., Andre J., Poitout V., Peters J.M., Gonzalez F.J., Fruchart J.C., Reach G., and Staels B. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50 (2001) 2809-2814
14. Han D.-H., Nolte L.A., Ju J.-S., Coleman T., Holloszy J.O., and Semenkovich C.F. UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E347-E353
15. Jamieson P.M., Nyirenda M.J., Walker B.R., Chapman K.E., and Seckl J.R. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1. J. Endocrinol. 160 (1999) 103-109
16. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
17. Koo S.H., Satoh H., Herzig S., Lee C.H., Hedrick S., Kulkarni R., Evans R.M., Olefsky J., and Montminy M. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 10 (2004) 530-534
18. Lam T.K., Pocai A., Gutierrez-Juarez R., Obici S., Bryan J., Aguilar-Bryan L., Schwartz G.J., and Rossetti L. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11 (2005) 320-327
19. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022
20. Lemberger T., Staels B., Saladin R., Desvergne B., Auwerx J., and Wahli W. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J. Biol. Chem. 269 (1994) 24527-24530
21. Lemberger T., Saladin R., Vazquez M., Assimacopoulos F., Staels B., Desvergne B., Wahli W., and Auwerx J. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271 (1996) 1764-1769
22. Magni F., and Carobi C. The afferent and preganglionic parasympathetic innervation of the rat liver, demonstrated by the retrograde transport of horseradish peroxidase. J. Auton. Nerv. Syst. 8 (1983) 237-260
23. Marshall B.A., Tordjman K., Host H.H., Ensor N.J., Kwon G., Marshall C.A., Coleman T., McDaniel M.L., and Semenkovich C.F. Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. J. Biol. Chem. 274 (1999) 27426-27432
24. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
25. Matsuhisa M., Yamasaki Y., Shiba Y., Nakahara I., Kuroda A., Tomita T., Iida M., Ikeda M., Kajimoto Y., Kubota M., and Hori M. Important role of the hepatic vagus nerve in glucose uptake and production by the liver. Metabolism 49 (2000) 11-16
26. Moreno S., Farioli-Vecchioli S., and Ceru M.P. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123 (2004) 131-145
27. Nahas Z., Marangell L.B., Husain M.M., Rush A.J., Sackeim H.A., Lisanby S.H., Martinez J.M., and George M.S. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry 66 (2005) 1097-1104
28. Obici S., Zhang B.B., Karkanias G., and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 12 (2002) 1376-1382
29. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., Seckl J.R., and Mullins J.J. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc. Natl. Acad. Sci. USA 101 (2004) 7088-7093
30. Patsouris D., Mandard S., Voshol P.J., Escher P., Tan N.S., Havekes L.M., Koenig W., Marz W., Tafuri S., Wahli W., et al. PPARalpha governs glycerol metabolism. J. Clin. Invest. 114 (2004) 94-103
31. Peitl B., Dobronte R., Nemeth J., Mezey G., Kovacs P., Paragh G., and Szilvassy Z. The prandial insulin sensitivity-modifying effect of vagal stimulation in rats. Metabolism 54 (2005) 579-583
32. Petrescu I., Bojan O., Saied M., Barzu O., Schmidt F., and Kuhnle H.F. Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5′-diphosphate as nucleotide substrate. Anal. Biochem. 96 (1979) 279-281
33. Randich A., Spraggins D.S., Cox J.E., Meller S.T., and Kelm G.R. Jejunal or portal vein infusions of lipids increase hepatic vagal afferent activity. Neuroreport 12 (2001) 3101-3105
34. Reddy J.K. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G1333-G1339
35. Rodriguez J.C., Gil-Gomez G., Hegardt F.G., and Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269 (1994) 18767-18772
36. Smith G.P., and Jerome C. Effects of total and selective abdominal vagotomies on water intake in rats. J. Auton. Nerv. Syst. 9 (1983) 259-271
37. Subramanian S., DeRosa M.A., Bernal-Mizrachi C., Laffely N., Cade W.T., Yarasheski K.E., Cryer P.E., and Semenkovich C.F. PPARα activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E1365-E1371
38. Tordjman K., Bernal-Mizrachi C., Zemany L., Weng S., Feng C., Zhang F., Leone T.C., Coleman T., Kelly D.P., and Semenkovich C.F. PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 107 (2001) 1025-1034
39. Tordjman K., Standley K., Bernal-Mizrachi C., Leone T., Coleman T., Kelly D.P., and Semenkovich C.F. PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells. J. Lipid Res. 43 (2002) 936-943
40. Uno K., Katagiri H., Yamada T., Ishigaki Y., Ogihara T., Imai J., Hasegawa Y., Gao J., Kaneko K., Iwasaki H., et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312 (2006) 1656-1659
41. Uthman B.M., Reichl A.M., Dean J.C., Eisenschenk S., Gilmore R., Reid S., Roper S.N., and Wilder B.J. Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation. Neurology 63 (2004) 1124-1126
42. Wada M., Connolly C.C., Tarumi C., Neal D.W., and Cherrington A.D. Hepatic denervation does not significantly change the response of the liver to glucagon in conscious dogs. Am. J. Physiol. 268 (1995) E194-E203
43. Walker B.R., Sang K.S., Williams B.C., and Edwards C.R. Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta. J. Hypertens. 12 (1994) 33-39
44. Wallerath T., Witte K., Schafer S.C., Schwarz P.M., Prellwitz W., Wohlfart P., Kleinert H., Lehr H.A., Lemmer B., and Forstermann U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc. Natl. Acad. Sci. USA 96 (1999) 13357-13362
45. Walls E.K., Wang F.B., Holst M.C., Phillips R.J., Voreis J.S., Perkins A.R., Pollard L.E., and Powley T.L. Selective vagal rhizotomies: a new dorsal surgical approach used for intestinal deafferentations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 269 (1995) 1279-1288
46. Whitworth J.A., Coghlan J.P., Denton D.A., Graham W.F., Humphery T.J., and Scoggins B.A. Comparison of the effects of 'glucocorticoid' and 'mineralocortocoid' infusions on blood pressure in sheep. Clin. Exp. Hypertens. 1 (1979) 649-663
47. Xie H., and Lautt W.W. Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am. J. Physiol. 271 (1996) E587-E592